Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

ADX-10059 achieves statistically significant outcome in GERD study

April 20, 2007

ME-3738 protects against acetaminophen-induced liver injury in mice

April 20, 2007

Studies show activity of ITMN-191 with other agents

April 20, 2007

Preclinical and clinical data on novel inhibitors of HCV NS5B polymerase and NS3 proteases

April 19, 2007

AGI receives FDA approval for phase III study of arverapamil

April 18, 2007

New therapeutic options for hepatitis C described in recent patent literature

April 18, 2007

Clevudine metabolism studied in human hepatocytes

April 18, 2007

LB-80317 shows broad spectrum anti-HBV activity against resistant mutants in vitro

April 17, 2007

New data indicate higher virologic response with celgosivir combination therapy

April 13, 2007

Hepatitis B surface antigen/1018-ISS combination shows promise

April 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...